Literature DB >> 23520328

SOX11 is a mantle cell lymphoma oncogene.

Adolfo A Ferrando1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23520328     DOI： 10.1182/blood-2013-02-480418

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry.

Authors:  Blanca Espinet; Ana Ferrer; Beatriz Bellosillo; Lara Nonell; Antonio Salar; Concepción Fernández-Rodríguez; Eulàlia Puigdecanet; Javier Gimeno; Mar Garcia-Garcia; Maria Carmen Vela; Elisa Luño; Rosa Collado; José Tomás Navarro; Esmeralda de la Banda; Pau Abrisqueta; Leonor Arenillas; Cristina Serrano; Josep Lloreta; Belén Miñana; Andrea Cerutti; Lourdes Florensa; Alberto Orfao; Ferran Sanz; Francesc Solé; David Dominguez-Sola; Sergio Serrano
Journal:  Clin Cancer Res       Date:  2013-12-18       Impact factor: 12.531

2.  Mantle cell lymphoma presenting as bilateral adrenal huge masses.

Authors:  Abtin Doroudinia; Mehrdad Bakhshayesh Karam; Mostafa Ranjbar; Arash Nikmanesh; Payam Mehrian
Journal:  BMJ Case Rep       Date:  2018-04-17

3.  Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype.

Authors:  Inmaculada Ribera-Cortada; Daniel Martinez; Virginia Amador; Cristina Royo; Alba Navarro; Silvia Beà; Eva Gine; Laurence de Leval; Sergio Serrano; Andrew Wotherspoon; Dolors Colomer; Antonio Martinez; Elías Campo
Journal:  Mod Pathol       Date:  2015-09-11       Impact factor: 7.842

4.  CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course.

Authors:  Zhihong Hu; Yi Sun; Ellen J Schlette; Guilin Tang; Shaoying Li; Jie Xu; C Cameron Yin; Ken H Young; Keyur Pravinchandra Patel; Roberto N Miranda; Maitrayee Goswami; Michael Wang; Jeffrey L Jorgensen; L Jeffrey Medeiros; Sa A Wang
Journal:  Mod Pathol       Date:  2017-10-06       Impact factor: 7.842

5.  Identification of miRNA-34a and miRNA-155 as prognostic markers for mantle cell lymphoma.

Authors:  Jianxia He; Yanfeng Xi; Ning Gao; Enwei Xu; Jin Chang; Jie Liu
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

Review 6.  Smoldering mantle cell lymphoma.

Authors:  Haige Ye; Aakash Desai; Dongfeng Zeng; Krystle Nomie; Jorge Romaguera; Makhdum Ahmed; Michael L Wang
Journal:  J Exp Clin Cancer Res       Date:  2017-12-15

7.  Highly sensitive and specific in situ hybridization assay for quantification of SOX11 mRNA in mantle cell lymphoma reveals association of TP53 mutations with negative and low SOX11 expression.

Authors:  Birgit Federmann; Leonie Frauenfeld; Helga Pertsch; Vanessa Borgmann; Julia Steinhilber; Irina Bonzheim; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Haematologica       Date:  2019-07-11       Impact factor: 9.941

8.  Cobblestone-area forming cells derived from patients with mantle cell lymphoma are enriched for CD133+ tumor-initiating cells.

Authors:  Daniel J Medina; Jeneba Abass-Shereef; Kelly Walton; Lauri Goodell; Hana Aviv; Roger K Strair; Tulin Budak-Alpdogan
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

9.  An overlapping case of in situ mantle cell neoplasia and leukemic non-nodal mantle cell lymphoma.

Authors:  Ryota Matsuoka; Noriaki Sakamoto; Mamiko Sakata-Yanagimoto; Shigeru Chiba; Masayuki Noguchi; Naoya Nakamura
Journal:  J Clin Exp Hematop       Date:  2020-10-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.